DRUG · Unmapped registry intervention
Truvada (fixed dose combination of tenofovir + emtricitabine) + Stocrin (efavirenz)
Find medicine records ·
Find other trials using this name
Clinical trial
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens
NCT00335322
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Truvada (fixed dose combination of tenofovir + emtricitabine)+ ritonavir/atazanavir (r/ATV)
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Truvada (fixed dose combination of tenofovir + emtricitabine) + zidovudine (ZDV) + abacavir (ABC)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Human Immunodeficiency Virus (HIV)unresolved
Interventions
Sponsors & collaborators
Kirby Institutelead sponsor
The University of New South Walescollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00335322 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.